A diffusible resistance factor(s) in spontaneous mitomycin resistant mammalian cancer cells. 1998

Z G Wan, and H Kobayashi, and A Hayakawa, and T Ishigaki
Department of Radiology, Nagoya University School of Medicine, Japan.

We developed a Mitomycin C (MMC)-resistant mouse breast cancer cell subline, R-FM3A, from FM3A parent cells(W-FM3A) by continuous exposure to a concentration of 0.01 microgram/ml MMC for over two months. R-FM3A cells were resistant to MMC and decreased in response to the combined effects of ionizing irradiation and MMC. The resistance to MMC and ionizing irradiation was mediated by a cell-free medium, in which R-FM3A cells were cultured for 12 hours without MMC (Re-medium). The cell cycles measured by means of a flow cytometer were not influenced by the Re-medium when W-FM3A cells were treated by MMC. But the cell cycles measured by means of a flow cytometer were influenced by the Re-medium when W-FM3A cells were irradiated at a dose of 4 Gy.

UI MeSH Term Description Entries
D008325 Mammary Neoplasms, Experimental Experimentally induced mammary neoplasms in animals to provide a model for studying human BREAST NEOPLASMS. Experimental Mammary Neoplasms,Neoplasms, Experimental Mammary,Experimental Mammary Neoplasm,Mammary Neoplasm, Experimental,Neoplasm, Experimental Mammary
D002453 Cell Cycle The complex series of phenomena, occurring between the end of one CELL DIVISION and the end of the next, by which cellular material is duplicated and then divided between two daughter cells. The cell cycle includes INTERPHASE, which includes G0 PHASE; G1 PHASE; S PHASE; and G2 PHASE, and CELL DIVISION PHASE. Cell Division Cycle,Cell Cycles,Cell Division Cycles,Cycle, Cell,Cycle, Cell Division,Cycles, Cell,Cycles, Cell Division,Division Cycle, Cell,Division Cycles, Cell
D002455 Cell Division The fission of a CELL. It includes CYTOKINESIS, when the CYTOPLASM of a cell is divided, and CELL NUCLEUS DIVISION. M Phase,Cell Division Phase,Cell Divisions,Division Phase, Cell,Division, Cell,Divisions, Cell,M Phases,Phase, Cell Division,Phase, M,Phases, M
D002470 Cell Survival The span of viability of a cell characterized by the capacity to perform certain functions such as metabolism, growth, reproduction, some form of responsiveness, and adaptability. Cell Viability,Cell Viabilities,Survival, Cell,Viabilities, Cell,Viability, Cell
D004058 Diffusion The tendency of a gas or solute to pass from a point of higher pressure or concentration to a point of lower pressure or concentration and to distribute itself throughout the available space. Diffusion, especially FACILITATED DIFFUSION, is a major mechanism of BIOLOGICAL TRANSPORT. Diffusions
D004351 Drug Resistance Diminished or failed response of an organism, disease or tissue to the intended effectiveness of a chemical or drug. It should be differentiated from DRUG TOLERANCE which is the progressive diminution of the susceptibility of a human or animal to the effects of a drug, as a result of continued administration. Resistance, Drug
D005260 Female Females
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000903 Antibiotics, Antineoplastic Chemical substances, produced by microorganisms, inhibiting or preventing the proliferation of neoplasms. Antineoplastic Antibiotics,Cytotoxic Antibiotics,Antibiotics, Cytotoxic
D014407 Tumor Cells, Cultured Cells grown in vitro from neoplastic tissue. If they can be established as a TUMOR CELL LINE, they can be propagated in cell culture indefinitely. Cultured Tumor Cells,Neoplastic Cells, Cultured,Cultured Neoplastic Cells,Cell, Cultured Neoplastic,Cell, Cultured Tumor,Cells, Cultured Neoplastic,Cells, Cultured Tumor,Cultured Neoplastic Cell,Cultured Tumor Cell,Neoplastic Cell, Cultured,Tumor Cell, Cultured

Related Publications

Z G Wan, and H Kobayashi, and A Hayakawa, and T Ishigaki
August 1999, Proceedings of the National Academy of Sciences of the United States of America,
Z G Wan, and H Kobayashi, and A Hayakawa, and T Ishigaki
January 1991, Anticancer research,
Z G Wan, and H Kobayashi, and A Hayakawa, and T Ishigaki
November 1985, Cancer research,
Z G Wan, and H Kobayashi, and A Hayakawa, and T Ishigaki
April 1968, Comptes rendus hebdomadaires des seances de l'Academie des sciences. Serie D: Sciences naturelles,
Z G Wan, and H Kobayashi, and A Hayakawa, and T Ishigaki
October 1987, Biochemical pharmacology,
Z G Wan, and H Kobayashi, and A Hayakawa, and T Ishigaki
May 2012, The American journal of the medical sciences,
Z G Wan, and H Kobayashi, and A Hayakawa, and T Ishigaki
December 1991, Experimental cell research,
Z G Wan, and H Kobayashi, and A Hayakawa, and T Ishigaki
May 1995, International journal of cancer,
Z G Wan, and H Kobayashi, and A Hayakawa, and T Ishigaki
September 1978, Journal of cellular physiology,
Copied contents to your clipboard!